Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
21
|
| pubmed:dateCreated |
1993-11-29
|
| pubmed:abstractText |
We have investigated the frequency of p53 gene mutations in Ewing's sarcoma (ES) and neuroblastoma (NB) by using polymerase chain reaction-single strand conformation polymorphism analysis for genomic DNA or complementary DNA generated from total RNA. Mutations of the p53 gene were found in six of seven ES cell lines: a missense mutation of TGC (Cys)-->TAC (Try) at codon 141 in one, a missense mutation of CGT (Arg)-->TGT (Cys) at codon 273 in one, a missense mutation of TGC (Cys)-->TTC (Phe) at codon 176 in three, and one base deletion of CGC-->CG at codon 283 in one. Further analysis of 14 ES and related primary tumors showed mutations of the p53 gene in only two: one base insertion of CCG-->CCCG at codon 152 in one and a missense mutation of GGC (Gly)-->GTC (Val) at codon 154 in the other. Both of the two tumors were obtained from patients with an advanced stage disease. Three of the eight ESs with mutations of the p53 gene showed the same missense mutation at codon 176, suggesting the mutational hot spot of the p53 gene in ESs. In contrast to ES, none of 6 NB cell lines or 48 NB tumors including advanced-stage ones with or without N-myc amplification showed any aberration of the p53 gene. Our findings suggest that mutations of the p53 gene in ES might represent late genetic events related to tumor progression, and that aberrations of the p53 gene might not be involved in the development or the progression of NB.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Nov
|
| pubmed:issn |
0008-5472
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
1
|
| pubmed:volume |
53
|
| pubmed:geneSymbol |
p53
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
N
|
| pubmed:pagination |
5284-8
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:8221663-Adolescent,
pubmed-meshheading:8221663-Adult,
pubmed-meshheading:8221663-Base Sequence,
pubmed-meshheading:8221663-Bone Neoplasms,
pubmed-meshheading:8221663-Cell Line,
pubmed-meshheading:8221663-Child,
pubmed-meshheading:8221663-Codon,
pubmed-meshheading:8221663-DNA Primers,
pubmed-meshheading:8221663-Exons,
pubmed-meshheading:8221663-Female,
pubmed-meshheading:8221663-Genes, p53,
pubmed-meshheading:8221663-Humans,
pubmed-meshheading:8221663-Male,
pubmed-meshheading:8221663-Molecular Sequence Data,
pubmed-meshheading:8221663-Neuroblastoma,
pubmed-meshheading:8221663-Point Mutation,
pubmed-meshheading:8221663-Polymerase Chain Reaction,
pubmed-meshheading:8221663-Sarcoma, Ewing,
pubmed-meshheading:8221663-Tumor Cells, Cultured
|
| pubmed:year |
1993
|
| pubmed:articleTitle |
Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.
|
| pubmed:affiliation |
Department of Pediatric Surgery, University of Tokyo, Japan.
|
| pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|